What InMed Prognostics does
Founded in 2018, InMed Prognostics operates in Health Tech industry. Initially focusing on neurodegenerative diseases, the company has leveraged imaging and AI to offer comprehensive diagnostic insights. InMed Prognostics announced a collaboration with several hospitals to enhance diagnostic accuracy and accessibility. The company has expanded its offerings to include partnerships with research institutions for broader data integration. In the Indian healthcare technology landscape, InMed Prognostics competes with global players such as Qure. Competing with companies such as Perfint Healthcare and Remidio.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about InMed Prognostics yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.